IP Library Granted Patent US 8,415,344
Granted Patent B2
US 8,415,344 · App. 13/307,033 · Granted Apr 9, 2013

Method of treating depression

Inventor: Fritz Henn (East Patchogue, NY)
Assignee: Brookhaven Science Associates, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,415,344
App. No.
13/307,033
Granted
Apr 9, 2013
Kind
B2
Abstract

Methods for treatment of depression-related mood disorders in mammals, particularly humans are disclosed. The methods of the invention include administration of compounds capable of enhancing glutamate transporter activity in the brain of mammals suffering from depression. ATP-sensitive K + channel openers and β-lactam antibiotics are used to enhance glutamate transport and to treat depression-related mood disorders and depressive symptoms.

Claims (2)

1. A method of treating a depressive symptom in a mammal comprising administering to the mammal in need of such treatment a therapeutically effective amount of a β-lactam antibiotic in combination with a K ATP channel opener wherein the channel opener is selected from the group consisting of diazoxide and iptakalim.

2. A method of treating a depression-related mood disorder in a mammal comprising administering to the mammal in need of such treatment a therapeutically effective amount of a β-lactam antibiotic in combination with a K ATP channel opener wherein the channel opener is selected from the group consisting of diazoxide and iptakalim.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 19, 2012
From: BROOKHAVEN SCIENCE ASSOCIATES, LLC
To: ENERGY, UNITED STATES OF DEPARTMENT OF
Reel/Frame 029016/0373 →
Continuity (2)
Division 12641968 · Dec 18, 2009
Related Publication 20120129826A1 · May 24, 2012